BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zare H, Shafabakhsh R, Reiter RJ, Asemi Z. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects. J Ovarian Res 2019;12:26. [PMID: 30914056 DOI: 10.1186/s13048-019-0502-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Huang J, Shan W, Li N, Zhou B, Guo E, Xia M, Lu H, Wu Y, Chen J, Wang B, Xi L, Ma D, Chen G, Li K, Sun C. Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice. Reprod Biomed Online 2021;42:505-19. [PMID: 33388265 DOI: 10.1016/j.rbmo.2020.10.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rezaei-Tazangi F, Roghani-Shahraki H, Khorsand Ghaffari M, Abolhasani Zadeh F, Boostan A, ArefNezhad R, Motedayyen H. The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence. Pharmaceuticals (Basel) 2021;14:1315. [PMID: 34959716 DOI: 10.3390/ph14121315] [Reference Citation Analysis]
3 Dun A, Zhao X, Jin X, Wei T, Gao X, Wang Y, Hou H. Association Between Night-Shift Work and Cancer Risk: Updated Systematic Review and Meta-Analysis. Front Oncol 2020;10:1006. [PMID: 32656086 DOI: 10.3389/fonc.2020.01006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Yao C, Liu X, Zhou Z, Xiang Y, Yuan S, Xie W, Zhou M, Hu Z, Li Y, Ji A, Cai T. Melatonin attenuates expression of cyclooxygenase-2 (COX-2) in activated microglia induced by lipopolysaccharide (LPS). J Toxicol Environ Health A 2019;82:437-46. [PMID: 31081481 DOI: 10.1080/15287394.2019.1615019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Faria VS, Pejon TMM, Gobatto CA, de Araujo GG, Cornachione AS, Beck WR. Acute melatonin administration improves exercise tolerance and the metabolic recovery after exhaustive effort. Sci Rep 2021;11:19228. [PMID: 34584111 DOI: 10.1038/s41598-021-97364-7] [Reference Citation Analysis]
6 Costanzi E, Simioni C, Conti I, Laface I, Varano G, Brenna C, Neri LM. Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives. J Cell Physiol 2021;236:2505-18. [PMID: 32989768 DOI: 10.1002/jcp.30062] [Reference Citation Analysis]
7 Reiter RJ, Sharma R. Central and peripheral actions of melatonin on reproduction in seasonal and continuous breeding mammals. Gen Comp Endocrinol 2021;300:113620. [PMID: 32950582 DOI: 10.1016/j.ygcen.2020.113620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Capote-Moreno A, Ramos E, Egea J, López-Muñoz F, Gil-Martín E, Romero A. Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics. Cancers (Basel) 2019;11:E1712. [PMID: 31684096 DOI: 10.3390/cancers11111712] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
9 Cesário RC, Gaiotte LB, Cucielo MS, Silveira HS, Dos Santos LD, de Campos Zuccari DAP, Seiva FRF, Reiter RJ, de Almeida Chuffa LG. The proteomic landscape of ovarian cancer cells in response to melatonin. Life Sci 2022;:120352. [PMID: 35074409 DOI: 10.1016/j.lfs.2022.120352] [Reference Citation Analysis]
10 Sadoughi F, Dana PM, Asemi Z, Shafabakhash R, Mohammadi S, Heidar Z, Mirzamoradi M, Targhazeh N, Mirzaei H. Molecular and cellular mechanisms of melatonin in breast cancer. Biochimie 2022:S0300-9084(22)00067-0. [PMID: 35341930 DOI: 10.1016/j.biochi.2022.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Gurunathan S, Qasim M, Kang MH, Kim JH. Role and Therapeutic Potential of Melatonin in Various Type of Cancers. Onco Targets Ther 2021;14:2019-52. [PMID: 33776451 DOI: 10.2147/OTT.S298512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Li Y, Zou J, Li B, Du J. Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells. J Cell Mol Med 2021;25:9543-56. [PMID: 34547170 DOI: 10.1111/jcmm.16894] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules 2021;26:2506. [PMID: 33923028 DOI: 10.3390/molecules26092506] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Brzecka A, Sarul K, Dyła T, Avila-Rodriguez M, Cabezas-Perez R, Chubarev VN, Minyaeva NN, Klochkov SG, Neganova ME, Mikhaleva LM, Somasundaram SG, Kirkland CE, Tarasov VV, Aliev G. The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer. Curr Genomics 2020;21:444-53. [PMID: 33093806 DOI: 10.2174/1389202921999200403151720] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Bjørklund G, Rajib SA, Saffoon N, Pen JJ, Chirumbolo S. Insights on Melatonin as an Active Pharmacological Molecule in Cancer Prevention: What's New? Curr Med Chem 2019;26:6304-20. [PMID: 29714136 DOI: 10.2174/0929867325666180501094850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Pourhanifeh MH, Mehrzadi S, Kamali M, Hosseinzadeh A. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways. Eur J Pharmacol 2020;886:173471. [PMID: 32877658 DOI: 10.1016/j.ejphar.2020.173471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]